Clinical Trials Browser

Phase 4 × Sleep Wake Disorders × Clear all

NCT04641819 2024-05-31

Yangzheng Compound Mixture in the Treatment of Sleep Disorder in Cancer Patients

Phase 4 Active not recruiting

Carcinoma, Sleep Wake Disorders